Trends and outcomes of peptic ulcer disease in patients with cirrhosis

References

• Bang CS, Baik GH, Kim JH, et al. Peptic ulcer disease in liver cirrhosis and chronic hepatitis: impact of portal hypertension. Scand J Gastroenterol. 2014;49(9):1051–1057.
   PubMed Web of Science ®Google Scholar
• Grucza RA, Sher KJ, Kerr WC, et al. Trends in adult alcohol use and binge drinking in the early 21st-century united states: a meta-analysis of 6 national survey series. Alcohol Clin Exp Res. 2018;42(10):1939–1950.
   PubMed Web of Science ®Google Scholar
• Orman ES, Roberts A, Ghabril M, et al. Trends in characteristics, mortality, and other outcomes of patients with newly diagnosed cirrhosis. JAMA Network Open. 2019;2(6):e196412.
   PubMed Web of Science ®Google Scholar
• Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 2010;251(1):51–58.
   PubMed Web of Science ®Google Scholar
• Kim DJ, Kim HY, Kim SJ, et al. Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Intern Med. 2008;23(1):16.
   Google Scholar
• Voulgaris T. High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis. Ann Gastroenterol. 2019. DOI:10.20524/aog.2019.0399
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Digestive Liver Dis. 2003;35(3):197–205.
   Web of Science ®Google Scholar
• Sung JJY, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29(9):938–946.
   PubMed Web of Science ®Google Scholar
• Calvet X, Navarro M, Gil M, et al. Epidemiology of peptic ulcer disease in cirrhotic patients: role of helicobacter pylori infection. Am J Gastroenterol. 1998;93(12):2501–2507.
   PubMed Web of Science ®Google Scholar
• Kirchner GI, Beil W, Bleck JS, et al. Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis. Int J Clin Exp Med. 2011;4(1):26–31.
   PubMed Web of Science ®Google Scholar
• Siringo S, Burroughs AK, Bolondi L, et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol. 1995;22(6):633–641.
   PubMed Web of Science ®Google Scholar
• Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc. 1995 Nov;42(5):424–427.
   PubMed Web of Science ®Google Scholar
• Huang J-Q, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359(9300):14–22.
   PubMed Web of Science ®Google Scholar
• Walcott B, Bashinskaya B, Nahed B, et al. Trends in peptic ulcer disease and the identification of helicobacter pylori as a causative organism: population-based estimates from the US nationwide inpatient sample. J Glob Infect Dis. 2011;3(4):366.
   PubMedGoogle Scholar
• Katoh M, Seta T, Takahashi Y, et al. Effectiveness of helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference. Plos One. 2017;12(8):e0183321.
   Web of Science ®Google Scholar
• Lo G-H, Yu H-C, Chan Y-C, et al. The effects of eradication of helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc. 2005;62(3):350–356.
   PubMed Web of Science ®Google Scholar
• Villalan R, Maroju NK, Kate V, et al. Is helicobacter pylori eradication indicated in cirrhotic patients with peptic ulcer disease? Trop Gastroenterol. 2006 Oct-Dec;27(4):166–168.
   PubMedGoogle Scholar
• Chang -S-S, Hu H-Y. Helicobacter pylori is not the predominant etiology for liver cirrhosis patients with peptic ulcer disease. Eur J Gastroenterol Hepatol. 2013;25(2):159–165.
   PubMed Web of Science ®Google Scholar
• Jung SW, Lee SW, Hyun JJ, et al. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Digestive Liver Dis. 2009;41(2):134–140.
   Web of Science ®Google Scholar
• Holland-Bill L, Christiansen CF, Gammelager H, et al. Chronic liver disease and 90-day mortality in 21 359 patients following peptic ulcer bleeding - a nationwide cohort study. Aliment Pharmacol Ther. 2015;41(6):564–572.
   PubMed Web of Science ®Google Scholar
• Hsu Y-C, Lin J-T, Chen -T-T, et al. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study. Hepatology. 2012;56(2):698–705.
   PubMed Web of Science ®Google Scholar
• Starkel P, Yang S-C, Hsu C-N, et al. Risk of rebleeding and mortality in cirrhotic patients with peptic ulcer bleeding: a 12-year nationwide cohort study. Plos One. 2017;12(1).
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Overview of the National (Nationwide) Inpatient Sample (NIS); [ cited 2020 Mar 31]. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp
   Google Scholar
• Solanki S, Haq KF, Chakinala RC, et al. Inpatient burden of esophageal varices in the United States: analysis of trends in demographics, cost of care, and outcomes. Ann Transl Med. 2019;7(18):480.
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Trend weights for HCUP NIS data; [ cited 2020 Mar 31]. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp
   Google Scholar
• Feinstein LB, Holman RC, Christensen KLY, et al. Trends in hospitalizations for peptic ulcer disease, United States, 1998–20051. Emerg Infect Dis. 2010;16(9):1410–1418.
   PubMed Web of Science ®Google Scholar
• Kanotra R, Ahmed M, Patel N, et al. Seasonal variations and trends in hospitalization for peptic ulcer disease in the United States: a 12-year analysis of the nationwide inpatient sample. Cureus. 2016. DOI:10.7759/cureus.854
   PubMed Web of Science ®Google Scholar
• Kramer JR, Davila JA, Miller ED, et al. The validity of viral hepatitis and chronic liver disease diagnoses in veterans affairs administrative databases. Aliment Pharmacol Ther. 2007;27(3):274–282.
   PubMed Web of Science ®Google Scholar
• Nehra MS, Ma Y, Clark C, et al. Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol. 2013;47(5):e50–e54.
   PubMed Web of Science ®Google Scholar
• Baram D, Daroowalla F, Garcia R, et al. Use of the All Patient Refined-Diagnosis Related Group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respir Pulm Med. 2008;2:CCRPM.S544.
   PubMedGoogle Scholar
• Li B, Evans D, Faris P, et al. Risk adjustment performance of charlson and elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8(1). DOI:10.1186/1472-6963-8-12
   Google Scholar
• Thirumurthi S, Desilva R, Castillo DL, et al. Identification ofHelicobacter pyloriinfected patients, using administrative data. Aliment Pharmacol Ther. 2008;28(11–12):1309–1316.
   PubMedGoogle Scholar
• Healthcare cost and utilization Project (HCUP). HCUP methods series. [ cited 2020 Apr 1]. Available from: https://www.hcup-us.ahrq.gov/reports/methods/2015_09.jsp
   Google Scholar
• Siringo S, Bolondi L, Piscaglia F, et al. Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. Ital J Gastroenterol Hepatol. 1997 Feb 29;1:62–68.
   PubMedGoogle Scholar
• Dore M, Mura D, Deledda S, et al. Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role ofhelicobacter pyloriinfection and portal hypertensive gastropathy. Can J Gastroenterol. 2004;18(8):521–524.
   PubMedGoogle Scholar
• Chang CS, Kao CH, Yeh HZ, et al. Helicobacter pylori infection and gastric emptying in cirrhotic patients with symptoms of dyspepsia. Hepatogastroenterology. 1999 Nov-Dec;46(30):3166–3171.
   PubMedGoogle Scholar
• Konturek SJ, Gonciarz M, Gonciarz Z, et al. Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis. Scand J Gastroenterol. 2009;38(6):643–647.
   Google Scholar
• Kamalaporn P, Sobhonslidsuk A, Jatchavala J, et al. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther. 2005;21(12):1459–1465.
   PubMed Web of Science ®Google Scholar
• Pellicano R, Leone N, Berrutti M, et al. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol. 2000;33(4):648–650.
   PubMed Web of Science ®Google Scholar
• Ponzetto A. Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med. 2000;56(6):206–210.
   PubMed Web of Science ®Google Scholar
• Zullo A, Rinaldi V, Meddi P, et al. Helicobacter pylori infection in dyspeptic cirrhotic patients. Hepatogastroenterology. 1999 Jan-Feb;46(25):395–400.
   PubMedGoogle Scholar
• Chen CT, Wang TF, Chan CC, et al. Role of chronic Helicobacter pylori infection in hyperdynamic circulation of cirrhotic patients. Hepatogastroenterology. 2002 Jan-Feb;49(43):208–212.
   PubMedGoogle Scholar
• McCormick PA, Sankey EA, Cardin F, et al. Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study. Gut. 1991;32(4):351–354.
   PubMed Web of Science ®Google Scholar
• Vergara M, Calvet X, Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol. 2002;14(7):717–722.
   PubMed Web of Science ®Google Scholar
• Tzathas C, Triantafyllou K, Mallas E, et al. Effect of helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients. J Clin Gastroenterol. 2008;42(6):744–749.
   PubMed Web of Science ®Google Scholar
• Chang -S-S, Hu H-Y. EarlyHelicobacter pylorieradication is associated with a reduced risk of recurrent peptic ulcers in cirrhotic patients. J Dig Dis. 2014;15(8):451–458.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Satoh H, Fukuda T, et al. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology. 1987;93(1):135–140.
   PubMed Web of Science ®Google Scholar
• Fraser AG, Pounder RE, Burroughs AK. Gastric secretion and peptic ulceration in cirrhosis. J Hepatol. 1993;19(1):171–182.
   PubMed Web of Science ®Google Scholar
• Sathar SA, Kunnathuparambil SG, Sreesh S, et al. Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy. Ann Gastroenterol. 2014;27(1):48–52.
   PubMedGoogle Scholar
• Saad RJ, Chey WD. Peptic ulcer disease in patients with chronic liver disease: looking beyond bugs and drugs. Gastrointest Endosc. 2005;62(3):357–359.
   PubMed Web of Science ®Google Scholar
• Schmidt ML, Barritt AS, Orman ES, et al. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology. 2015;148(5):967–977.e2.
   PubMed Web of Science ®Google Scholar
• Luo JC, Leu HB, Hou MC, et al. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther. 2012;36(6):542–550.
   PubMed Web of Science ®Google Scholar
• Venkatesh PGK, Parasa S, Njei B, et al. Increased mortality with peptic ulcer bleeding in patients with both compensated and decompensated cirrhosis. Gastrointest Endosc. 2014;79(4):605–614.e3.
   PubMed Web of Science ®Google Scholar
• González-González JA, García-Compean D, Vázquez-Elizondo G, et al. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study. Ann Hepatol. 2011;10(3):287–295.
   PubMed Web of Science ®Google Scholar
• Mathur AK, Chakrabarti AK, Mellinger JL, et al. Hospital resource intensity and cirrhosis mortality in United States. World J Gastroenterol. 2017;23(10):1857.
   PubMed Web of Science ®Google Scholar
• Scaglione S, Kliethermes S, Cao G, et al. The epidemiology of cirrhosis in the United States. J Clin Gastroenterol. 2015;49(8):690–696.
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Andersen PK, et al. Socioeconomic status and survival of cirrhosis patients: A Danish nationwide cohort study. BMC Gastroenterol. 2009;9(1). DOI:10.1186/1471-230X-9-35
   Google Scholar
• Sahni S, Talwar A, Khanijo S, et al. Socioeconomic status and its relationship to chronic respiratory disease. Adv Respir Med. 2017;85(2):97–108.
   PubMed Web of Science ®Google Scholar
• Johnsen R, Forde OH, Straume B, et al. Aetiology of peptic ulcer: a prospective population study in Norway. J Epidemiol Community Health. 1994;48(2):156–160.
   PubMed Web of Science ®Google Scholar
• Levenstein S, Kaplan GA. Socioeconomic status and ulcer. J Clin Gastroenterol. 1998;26(1):14–17.
   PubMed Web of Science ®Google Scholar
• Nasiry R, Piper DW. Social aspects of chronic duodenal ulcer. Digestion. 1983;27(4):196–202.
   PubMed Web of Science ®Google Scholar
• Setiawan VW, Stram DO, Porcel J, et al. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology. 2016;64(6):1969–1977.
   PubMed Web of Science ®Google Scholar
• Tillmann H, Mukthinuthalapati VVPK, Akinyeye S, et al. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. Plos One. 2019;14(3).
   Web of Science ®Google Scholar
• Leontiadis GI, Molloy-Bland M, Moayyedi P, et al. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(3):331–345.
   PubMed Web of Science ®Google Scholar
• Amitrano L, Guardascione MA, Manguso F, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol. 2012;107(12):1872–1878.
   PubMed Web of Science ®Google Scholar
• Ardevol A, Ibañez-Sanz G, Profitos J, et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2018;67(4):1458–1471.
   PubMed Web of Science ®Google Scholar
• Li X, Jiao Y, Xing Y, et al. Diabetes mellitus and risk of hepatic fibrosis/cirrhosis. Biomed Res Int. 2019;2019:1–8.
   Web of Science ®Google Scholar
• Sung JJY, Tsoi KKF, Ma TKW, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010;105(1):84–89.
   PubMed Web of Science ®Google Scholar
• Cerqueira de Carvalho G, de Andrade Regis C, Rosário Kalil J, et al. Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality. Ann Hepatol. 2012;11(1):90–95.
   PubMed Web of Science ®Google Scholar
• Fede G, D’Amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol. 2012;56(4):810–818.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Liang -C-C, Muo C-H, et al. Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications. PLoS One. 2014;9(2).
   Web of Science ®Google Scholar
• Parasa S, Navaneethan U, Sridhar ARM, et al. End-stage renal disease is associated with worse outcomes in hospitalized patients with peptic ulcer bleeding. Gastrointest Endosc. 2013;77(4):609–616.
   PubMed Web of Science ®Google Scholar
• Bianchi G, Marchesini G, Zoli M, et al. Prognostic significance of diabetes in patients with cirrhosis. Hepatology. 1994;20(1):119–125.
   PubMed Web of Science ®Google Scholar
• Davis TME, Peters KE, Bruce DG, et al. Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with Type 2 diabetes: the fremantle diabetes study. J Clin Endocrinol Metab. 2012;97(5):1581–1588.
   PubMed Web of Science ®Google Scholar
• de Marco R, Locatelli F, Zoppini G, et al. Cause-specific mortality in type 2 diabetes. The verona diabetes study. Diabetes Care. 1999;22(5):756–761.
   PubMed Web of Science ®Google Scholar
• Goh G-B-B, Pan A, Chow W-C, et al. Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese health study. Liver Int. 2017;37(2):251–258.
   PubMed Web of Science ®Google Scholar
• Harrison SA. Liver disease in patients with diabetes mellitus. J Clin Gastroenterol. 2006;40(1):68–76.
   PubMed Web of Science ®Google Scholar
• Moreau R, Delegue P, Pessione F, et al. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int. 2004;24(5):457–464.
   PubMed Web of Science ®Google Scholar
• Nishida T, Tsuji S, Tsujii M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol. 2006;101(1):70–75.
   PubMed Web of Science ®Google Scholar
• Omar Jáquez Quintana J, García-Compean D, Alberto González González J, et al. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Ann Hepatol. 2011;10(1):56–62.
   PubMed Web of Science ®Google Scholar
• Trombetta M, Spiazzi G, Zoppini G, et al. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther. 2005;22(s2):24–27.
   PubMedGoogle Scholar